• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放疗治疗颈静脉鼓室副神经节瘤的回归和局部控制率:系统评价和荟萃分析。

Regression and local control rates after radiotherapy for jugulotympanic paragangliomas: systematic review and meta-analysis.

机构信息

Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Radiother Oncol. 2013 Feb;106(2):161-8. doi: 10.1016/j.radonc.2012.11.002. Epub 2013 Jan 16.

DOI:10.1016/j.radonc.2012.11.002
PMID:23332889
Abstract

The primary treatment goal of radiotherapy for paragangliomas of the head and neck region (HNPGLs) is local control of the tumor, i.e. stabilization of tumor volume. Interestingly, regression of tumor volume has also been reported. Up to the present, no meta-analysis has been performed giving an overview of regression rates after radiotherapy in HNPGLs. The main objective was to perform a systematic review and meta-analysis to assess regression of tumor volume in HNPGL-patients after radiotherapy. A second outcome was local tumor control. Design of the study is systematic review and meta-analysis. PubMed, EMBASE, Web of Science, COCHRANE and Academic Search Premier and references of key articles were searched in March 2012 to identify potentially relevant studies. Considering the indolent course of HNPGLs, only studies with ≥ 12 months follow-up were eligible. Main outcomes were the pooled proportions of regression and local control after radiotherapy as initial, combined (i.e. directly post-operatively or post-embolization) or salvage treatment (i.e. after initial treatment has failed) for HNPGLs. A meta-analysis was performed with an exact likelihood approach using a logistic regression with a random effect at the study level. Pooled proportions with 95% confidence intervals (CI) were reported. Fifteen studies were included, concerning a total of 283 jugulotympanic HNPGLs in 276 patients. Pooled regression proportions for initial, combined and salvage treatment were respectively 21%, 33% and 52% in radiosurgery studies and 4%, 0% and 64% in external beam radiotherapy studies. Pooled local control proportions for radiotherapy as initial, combined and salvage treatment ranged from 79% to 100%. Radiotherapy for jugulotympanic paragangliomas results in excellent local tumor control and therefore is a valuable treatment for these types of tumors. The effects of radiotherapy on regression of tumor volume remain ambiguous, although the data suggest that regression can be achieved at least in some patients. More research is needed to identify predictors for treatment success.

摘要

头颈部副神经节瘤(HNPGL)放射治疗的主要治疗目标是局部控制肿瘤,即稳定肿瘤体积。有趣的是,也有报道称肿瘤体积有消退。截至目前,尚无荟萃分析全面概述 HNPGL 放疗后的消退率。主要目的是进行系统评价和荟萃分析,以评估 HNPGL 患者放疗后肿瘤体积的消退情况。第二个结果是局部肿瘤控制。研究设计为系统评价和荟萃分析。2012 年 3 月,检索了 PubMed、EMBASE、Web of Science、COCHRANE 和 Academic Search Premier 以及关键文章的参考文献,以确定潜在相关的研究。考虑到 HNPGL 生长缓慢,只有随访时间≥12 个月的研究才有资格纳入。主要结局是 HNPGL 初始、联合(即直接术后或栓塞后)或挽救治疗(即初始治疗失败后)放疗后的肿瘤消退和局部控制的汇总比例。使用具有随机效应的逻辑回归进行精确似然方法进行荟萃分析。以 95%置信区间(CI)报告汇总比例。纳入了 15 项研究,涉及 276 例患者的 283 例颈静脉鼓室副神经节瘤。在放射外科研究中,初始、联合和挽救治疗的肿瘤消退汇总比例分别为 21%、33%和 52%,在外部束放射治疗研究中分别为 4%、0%和 64%。初始、联合和挽救治疗的局部控制汇总比例范围为 79%至 100%。放射治疗颈静脉鼓室副神经节瘤可获得极好的局部肿瘤控制,因此是治疗此类肿瘤的有价值方法。放射治疗对肿瘤体积消退的影响仍存在争议,尽管数据表明至少在一些患者中可以实现消退。需要进一步研究以确定治疗成功的预测因素。

相似文献

1
Regression and local control rates after radiotherapy for jugulotympanic paragangliomas: systematic review and meta-analysis.放疗治疗颈静脉鼓室副神经节瘤的回归和局部控制率:系统评价和荟萃分析。
Radiother Oncol. 2013 Feb;106(2):161-8. doi: 10.1016/j.radonc.2012.11.002. Epub 2013 Jan 16.
2
Interventions for the management of dry mouth: non-pharmacological interventions.口干管理的干预措施:非药物干预措施
Cochrane Database Syst Rev. 2013 Aug 30(8):CD009603. doi: 10.1002/14651858.CD009603.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
5
Interventions for the management of dry mouth: non-pharmacological interventions.口干管理的干预措施:非药物干预
Cochrane Database Syst Rev. 2013 Sep 5;2013(9):CD009603. doi: 10.1002/14651858.CD009603.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
8
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.对于月经过多患者,在进行子宫内膜破坏术前使用的术前子宫内膜减薄剂。
Cochrane Database Syst Rev. 2013 Nov 15;2013(11):CD010241. doi: 10.1002/14651858.CD010241.pub2.
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

引用本文的文献

1
Molecular Genetics of Pheochromocytoma/Paraganglioma.嗜铬细胞瘤/副神经节瘤的分子遗传学
Curr Opin Endocr Metab Res. 2024 Sep;36. doi: 10.1016/j.coemr.2024.100527. Epub 2024 May 31.
2
Effectiveness of Artificial Intelligence Technologies in Cancer Treatment for Older Adults: A Systematic Review.人工智能技术在老年癌症治疗中的有效性:一项系统综述。
J Clin Med. 2024 Aug 23;13(17):4979. doi: 10.3390/jcm13174979.
3
Paragangliomas of the head and neck: a contemporary review.头颈部副神经节瘤:当代综述
Endocr Oncol. 2022 Nov 10;2(1):R153-R162. doi: 10.1530/EO-22-0080. eCollection 2022 Jan.
4
GammaKnife radiosurgery for Fisch-classified jugulotympanic paragangliomas: Review of the measures and timing of treatment success.伽玛刀放射外科治疗 Fisch 分级的颈静脉鼓室副神经节瘤:治疗成功的措施及时机回顾
J Radiosurg SBRT. 2022;8(3):211-215.
5
Sunitinib Treatment for Advanced Paraganglioma: Case Report of a Novel SDHD Gene Mutation Variant and Systematic Review of the Literature.舒尼替尼治疗晚期副神经节瘤:一例新型SDHD基因突变变体的病例报告及文献系统综述
Front Oncol. 2021 Jun 17;11:677983. doi: 10.3389/fonc.2021.677983. eCollection 2021.
6
High-specific-activity iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma.高比活度碘代甲苄胍治疗无法手术的嗜铬细胞瘤和副神经节瘤。
Future Oncol. 2021 Apr;17(10):1131-1141. doi: 10.2217/fon-2020-0625. Epub 2021 Jan 28.
7
Precision Surgery for Pheochromocytomas and Paragangliomas.精准外科手术治疗嗜铬细胞瘤和副神经节瘤
Horm Metab Res. 2019 Jul;51(7):470-482. doi: 10.1055/a-0926-3618. Epub 2019 Jul 15.
8
External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma.晚期/不可切除恶性副神经节瘤和嗜铬细胞瘤的外照射放射治疗
Adv Radiat Oncol. 2017 Nov 22;3(1):25-29. doi: 10.1016/j.adro.2017.11.002. eCollection 2018 Jan-Mar.
9
Head-to-head comparison between F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas.F-FDOPA PET/CT与MR/CT血管造影术在临床复发性头颈部副神经节瘤中的直接比较
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):979-987. doi: 10.1007/s00259-016-3605-0. Epub 2017 Jan 3.
10
Sleep-mediated heart rate variability after bilateral carotid body tumor resection.双侧颈动脉体瘤切除术后睡眠介导的心率变异性
Sleep. 2015 Apr 1;38(4):633-9. doi: 10.5665/sleep.4586.